[National Procurement of Influenza Vaccine: Bidding and Supply Method Improvement]

This report examines improvements in the bidding and supply methods for the National Influenza Vaccination Support Program, focusing on key changes and their outcomes during the 2022-2023 season. The previous mixed bidding system, combined with the individual private purchase method, led to imbalances in vaccine supply and administrative inefficiencies. To address these issues, the vaccine supply method was unified into a pre-supply system and the bidding process was transitioned to a competitive model based on desired quantities from vaccine manufacturers and importers. These improvements ensured supply stability, reduced administrative burdens, and enhanced the cold chain and safety measures during vaccine redistribution. As a result, the number of failed bids decreased, the time required for bidding and contracting processes were shortened, and regional vaccine supply imbalances were addressed. However, some limitations remain, such as the continued application of the individual private purchase method in certain areas, which requires further improvement. This report evaluates the limitations of the current supply method and suggests strategies for enhancing the vaccine supply system to improve stability and efficiency.